AstraZeneca plc vs Public Storage — how do they compare? AstraZeneca plc trades at $169.3 (market cap $253.13B), while Public Storage trades at $317.44 (market cap $56.00B). The key difference: AstraZeneca plc is far larger — about 4.5× Public Storage's market cap, and Public Storage pays the higher dividend (3.76%). Which is the better fit depends on your goals.
| AZN | PSA | |
|---|---|---|
Market Cap | $253.13B | $56.00B |
Sector | Health | Real Estate |
52-Week High | $209.48 | $329.64 |
52-Week Low | $137.44 | $258.44 |
Enterprise Value | $279.37B | $70.25B |
Dividend Yield | 1.92% | 3.76% |
Signals from Pluang's Aura AI — not financial advice
AstraZeneca (AZN) trades at $169.47, down 1.25% amid recent volatility following a Phase III trial failure for Wainua. The stock shows bearish technical signals with key support at $168 and resistance at $170. Fundamentally, the company reported strong 2025 results with revenue of $58.74B and net income of $10.23B, though a recent $1.5B licensing deal for a lung cancer drug highlights ongoing pipeline investments. Analyst sentiment is mixed with 47.5% buy ratings but recent downgrades from firms like HSBC citing trial setbacks.
The outlook balances robust financials against pipeline execution risks. Revenue growth and high margins support valuation, but the Wainua failure raises concerns about future catalysts. Investors should weigh the company's strong cash flow and market position against clinical trial volatility and potential legal investigations. Near-term price action may hinge on Q2 2026 earnings due July 27, 2026.
Public Storage (PSA) trades at $321.86, up 0.41% on the day, with a neutral technical signal and strong profitability metrics including a 39.16% net income margin and 33.78% ROE. Recent earnings beats and the pending acquisition of National Storage Affiliates highlight strategic growth initiatives, supported by a $3.00 dividend and robust cash flow from operations of $3.19B in 2025.
The outlook is positive with a consensus price target of $332.25, though elevated valuation ratios (P/E 33.25) and integration risks from acquisitions pose challenges. Earnings growth and market expansion into Canada are key catalysts, while interest rate sensitivity and competitive pressures remain watchpoints for investors.
Trailing returns across standard periods
Latest headlines on both assets
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →Public Storage is the largest owner of self-storage facilities in the U.S. with more than 2,800 self-storage facilities in 39 states and approximately 200 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage and to an additional 28 million net rentable square feet of industrial space in the United States through PS Business Parks.
Read more on PSA →